Literature DB >> 19916023

Expression of metalloproteases and their inhibitors in different histological types of breast cancer.

J M Del Casar1, S González-Reyes, L O González, J M González, S Junquera, M Bongera, M F García, A Andicoechea, C Serra, F J Vizoso.   

Abstract

PURPOSE: Metalloproteases (MMPs) and their tissue inhibitors of metalloproteases (TIMPs) are involved in several key aspects of tumoral growth, invasion and metastasis. The purpose of this study was to characterize on how the different histological types of breast cancer differ in the expression of several components of this enzymatic system.
METHODS: An immunohistochemical study was performed in 50 ductal, 23 lobular, 14 mucinous, 7 tubular, 4 papillary and 5 medullary invasive carcinomas, using tissue arrays and specific antibodies against 7 MMPs and 3 tisullar TIMPs. Staining results were categorized by means of a specific software program (score values).
RESULTS: Carcinomas of the ductal type showed higher score values for MMPs and TIMPs than the other histological types; whereas mucinous carcinomas had lower scores values for expressions of the majority of these proteins. Stromal fibroblasts were more frequently positive for MMP-1, -7 and -13 and TIMP-1 and -3, when present in carcinomas of the ductal type than in other histological types of breast carcinomas. Stromal mononuclear inflammatory cells were more frequently positive for MMP-1 and TIMP-3, but more often negative for MMP-7, -9 and -11, when located in carcinomas of the ductal type than in other histological types of breast carcinomas.
CONCLUSIONS: We found variations in MMP/TIMP expressions among the different histological subtypes of breast carcinomas suggesting differences in their tumor pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19916023     DOI: 10.1007/s00432-009-0721-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  57 in total

1.  Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06.

Authors:  E R Fisher; S Anderson; E Tan-Chiu; B Fisher; L Eaton; N Wolmark
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

Review 2.  Stromal effects on mammary gland development and breast cancer.

Authors:  Bryony S Wiseman; Zena Werb
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

Review 3.  Tissue inhibitor of metalloproteinases-1 in breast cancer.

Authors:  S Ø Würtz; A-S Schrohl; N Møller Sørensen; U Lademann; I J Christensen; H Mouridsen; N Brünner
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

4.  Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma.

Authors:  Z Dong; R Kumar; X Yang; I J Fidler
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

5.  p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.

Authors:  M J Rey; P L Fernández; P Jares; M Muñoz; A Nadal; N Peiró; I Nayach; C Mallofré; J Muntané; E Campo; J Estapé; A Cardesa
Journal:  J Pathol       Date:  1998-03       Impact factor: 7.996

6.  Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer.

Authors:  D H Kim; D S Yoon; W C Dooley; E S Nam; J W Ryu; K C Jung; H R Park; J H Sohn; H S Shin; Y E Park
Journal:  Histopathology       Date:  2003-01       Impact factor: 5.087

7.  Biochemical characterization of human collagenase-3.

Authors:  V Knäuper; C López-Otin; B Smith; G Knight; G Murphy
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

8.  Relationship between breast histopathology and family history of breast cancer.

Authors:  E B Claus; N Risch; W D Thompson; D Carter
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

9.  Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

Authors:  X Sastre-Garau; M Jouve; B Asselain; A Vincent-Salomon; P Beuzeboc; T Dorval; J C Durand; A Fourquet; P Pouillart
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

10.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

Authors:  V Noë; B Fingleton; K Jacobs; H C Crawford; S Vermeulen; W Steelant; E Bruyneel; L M Matrisian; M Mareel
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

View more
  8 in total

1.  A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.

Authors:  Noemí Eiró; Belen Fernandez-Garcia; Julio Vázquez; José M Del Casar; Luis O González; Francisco J Vizoso
Journal:  Oncoimmunology       Date:  2015-01-29       Impact factor: 8.110

Review 2.  A new paradigm for mechanobiological mechanisms in tumor metastasis.

Authors:  Peter A Torzilli; Jonathan W Bourne; Tessa Cigler; C Theresa Vincent
Journal:  Semin Cancer Biol       Date:  2012-05-18       Impact factor: 15.707

3.  Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.

Authors:  Tamotsu Takeuchi; Yoshihiro Adachi; Tomoko Nagayama; Mutsuo Furihata
Journal:  Virchows Arch       Date:  2011-07-20       Impact factor: 4.064

4.  Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients.

Authors:  Noemí Eiró; Salomé González-Reyes; Lucía González; Luis O González; Antonio Altadill; Alejandro Andicoechea; Manuel F Fresno-Forcelledo; Luis Rodrigo-Sáez; F J Vizoso
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

5.  MMP-1 expression has an independent prognostic value in breast cancer.

Authors:  Pia Boström; Mirva Söderström; Tero Vahlberg; Karl-Ove Söderström; Peter J Roberts; Olli Carpén; Pirkko Hirsimäki
Journal:  BMC Cancer       Date:  2011-08-11       Impact factor: 4.430

Review 6.  MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin.

Authors:  Giulia M Stella; Silvia Benvenuti; Alessandra Gentile; Paolo M Comoglio
Journal:  EBioMedicine       Date:  2017-09-21       Impact factor: 8.143

Review 7.  Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.

Authors:  Maria Aparecida Azevedo Koike Folgueira; Simone Maistro; Maria Lucia Hirata Katayama; Rosimeire Aparecida Roela; Fiorita Gonzales Lopes Mundim; Suely Nanogaki; Geertruida H de Bock; M Mitzi Brentani
Journal:  Biosci Rep       Date:  2013-12-12       Impact factor: 3.840

8.  Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.

Authors:  Zuzana Cierna; Michal Mego; Pavol Janega; Marian Karaba; Gabriel Minarik; Juraj Benca; Tatiana Sedlácková; Silvia Cingelova; Paulina Gronesova; Denisa Manasova; Daniel Pindak; Jozef Sufliarsky; Ludovit Danihel; James M Reuben; Jozef Mardiak
Journal:  BMC Cancer       Date:  2014-06-28       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.